Introduction
Nuclear Medicine/Radiopharmaceuticals Market was valued at USD XX Billion in 2019 and is projected to reach USD XX billion by 2025, at a CAGR of XX% from 2020-2025. The high growth of nuclear medicines across the globe is the major driver for the increase in the Nuclear Medicine/Radiopharmaceuticals Market. Factors such as increasing cancer, cardiac ailments and various related diseases are also heavily contributing to the growth of this market. Increasing awareness among people and various government initiates and facilities to provide prevalent patients with adequate diagnosis and care are also improving the conditions of the market in various continents. Easy availability and the initiatives taken by various organizations to lessen the demand-supply gap of Mo-99 and other related radioactive elements used to is also forecasted to significantly increase the Nuclear Medicine/Radiopharmaceuticals Market.
On the other hand, factors like short life of radioactive pharmaceuticals, the storage, and transport and logistics difficulties of these elements and also the high cost hinders the growth of the market in various regions.
Geographical Overview
At global level, North America region holds the highest market share in 2019 due to the advanced facilities and infrastructure available. Whereas, Asia Pacific region is considered the fastest-growing region with key players adopting expansion strategy in this region to gain maximum market share in the coming years. China and India are offering ample opportunities for the growth of Nuclear Medicine/Radiopharmaceuticals Market with its high population base. Key factors such as government initiatives and changing infrastructures of the regions are also driving Nuclear Medicine/Radiopharmaceuticals Market in the Asia Pacific region.
?
Segmental Overview
Nuclear Medicine/Radiopharmaceuticals Market is segmented as per below specifications -
By Type:
• Diagnostic Nuclear Medicine
o SPECT Radiopharmaceuticals
? Technetium-99m
? Thallium-201
? Gallium-67
? Iodine-123
? Other SPECT Isotopes
o PET Radiopharmaceuticals
? F-18
? Ru-82
? Other PET Isotopes
• Therapeutic Nuclear Medicine
o Alpha Emitters
? Ra-223
o Beta Emitters
? Iodine-131
? Yttrium-90
? Samarium-153
? Lutetium-177
? Rhenium-186
? Other Beta Emitters
• Brachytherapy Isotopes
o Iodine-125
o Palladium-103
o Cesium-131
o Iridium-192
o Other Brachytherapy Isotopes
By Application:
• Diagnostic Applications
o SPECT Applications
o Cardiology
? Bone Scans
? Thyroid Applications
? Pulmonary Scans
? Other SPECT Applications
o PET Applications
? Oncology
? Cardiology
? Neurology
? Other PET Applications
o Therapeutic Applications
? Thyroid Indications
? Bone Metastasis
? Lymphoma
? Endocrine Tumors
? Other Indications
By Procedural Volume Assessment:
• Diagnostic Procedures
o SPECT Procedures
o PET Procedures
• Therapeutic Procedures
o Beta Emitter Procedures
o Alpha Emitter Procedures
o Brachytherapy Procedures
Competitor Analysis
Nuclear Medicine/Radiopharmaceuticals Market has presence of some of the key major players across globe which includes
• Advanced Accelerator Applications S.A.
• Iba Molecular
• Nordion, Inc.
• Eczacibasi-Monrol Nuclear Products
• Siemens Healthcare
• Sigma Aldrich Corporation
• Bracco Imaging S.P.A
• Bayer AG
• Jubilant Pharma
• Nordien, Inc.
• Lantheus Medical Imaging, Inc.
• GE Healthcare
• Mallinckrodt PLC
• Cardinal Health, Inc.
• Medtronic Plc.
These key players are concentrating its efforts on the continuous product improvement with innovative initiatives to have an edge over other competitors. Further, to garner maximum market share, companies are adopting merger/ acquisition/ partnership and maintaining strong distribution networks strategies.
By Geographical Locations:
• North America
o U.S.
o Canada
• Europe
o U.K.
o France
o Italy
o Germany
o Spain
o Russia & CIS
o Rest of Europe
• Asia-Pacific
o China
o India
o Japan
o South Korea
o ASEAN
o Rest of Asia Pacific
• Latin America
o Brazil
o Argentina
o Rest of LATAM
• Middle East & Africa
o UAE
o South Africa
o Rest of MEA
?
Highlights of the report
What is Nuclear Medicine/Radiopharmaceuticals Market?
Who all are key market players in the industry?
How the Parent Industry is growing?
Where are the key opportunities for new market entrant?
A comprehensive analysis, which covers key growth factors across the value chain
Recent developments in market
Granular Market Segmentation
Market size projection based on Historical & current market trends
Market share analysis and key strategies adopted by Leading Players
Production Cost & Sensitivity Analysis
Country Level Market Analysis of Top 16 countries
Data Driven Decision Recommendations
Chapter 1 Research Objective
1.1 Need of the Research Report
1.2 Client Objectives
1.3 Offered Solutions
Chapter 2 Recommendations
2.1 Executive Summary
2.1.1 Market Overview
2.1.2 Competitive Insights
2.1.3 Segmental Analysis
2.1.4 Geographical Market Details
2.2 Lead Generation
2.3 Consultant
2.4 Return on Investment
Chapter 3 Research Methodology
3.1 Chromatus Database
3.2 Paid Sources
3.3 Primary Data Collection
3.3.1 Email Surveys
3.3.2 Telephonic Interviews
3.3.3 Face to Face Interviews
3.4 Secondary Data Collection
3.4.1 Annual Reports
3.4.2 Government Publications
3.4.3 Trade Data
3.4.4 Association Data
3.4.5 Research Papers/ Blogs/ News Articles
3.5 Expert Advisory Panel
3.6 Data Analytics Model
Chapter 4 Nuclear Medicine/Radiopharmaceuticals Market Overview
4.1 Parent Market Overview
4.2 Patent Analysis
4.3 PESTEL Analysis
4.3.1 Political
4.3.2 Economical
4.3.3 Social
4.3.4 Technological
4.3.5 Legal
4.4 SWOT Analysis
4.4.1 Strengths
4.4.2 Weakness
4.4.3 Opportunities
4.4.4 Threats
4.5 Regulations
4.6 Value Chain/ Supply Chain Analysis
4.7 Procurement & Vendor Analysis
4.8 Porters Five Analysis
4.8.1 Threat of new entrants
4.8.2 Bargaining power of suppliers
4.8.3 Bargaining power of buyers
4.8.4 Threat of substitutes
4.8.5 Competitive rivalry
Chapter 5 Regional Analysis
Global Nuclear Medicine/Radiopharmaceuticals Market Estimation and Forecast, 2019 - 2025 (USD Billion)
5.1 North America Market
5.1.1 U.S.
5.1.1 Canada
5.2 Europe Market
5.2.1 UK
5.2.2 Germany
5.2.3 France
5.2.4 Spain
5.2.5 Italy
5.2.6 Russia& CIS
5.2.7 Rest of Europe
5.3 Asia Pacific Market
5.3.1 China
5.3.2 Japan
5.3.3 India
5.3.4 South Korea
5.3.5 ASEAN
5.3.6 Rest of Asia Pacific
5.4 Rest of the World
5.4.1 Latin America
5.4.1.1 Brazil
5.4.1.2 Argentina
5.4.1.3 Rest of Latin America
5.4.2 Middle East
5.4.3 Africa
Chapter 6 Company Profile
6.1 Advanced Accelerator Applications S.A.
6.1.1 Introduction
6.1.2 Financial Overview
6.1.3 Product Portfolio
6.1.4 Recent Developments
6.1.5 SWOT Analysis
6.2 Iba Molecular
6.3 Nordion, Inc.
6.4 Eczacibasi-Monrol Nuclear Products
6.5 Siemens Healthcare
6.6 Sigma Aldrich Corporation
6.7 Bracco Imaging S.P.A
6.8 Bayer AG
6.9 Jubilant Pharma
6.10 Nordien, Inc.
6.11 Lantheus Medical Imaging, Inc.
6.12 GE Healthcare
6.13 Mallinckrodt PLC
6.14 Cardinal Health, Inc.
6.15 Medtronic Plc.
Chapter 7 Competitor Analysis
7.1 Company Ranking
7.2 Key Innovators
7.3 Market Leader
7.4 Emerging Players
7.5 Strategic Alliances
7.6 Competitive Matrix of 15 Companies
Chapter 8 Global Nuclear Medicine/Radiopharmaceuticals Market by Type Estimation and Forecast, 2019 - 2025 (USD Billion)
8.1 Diagnostic Nuclear Medicine
8.1.1 SPECT Radiopharmaceuticals
8.1.1.1 Technetium-99m
8.1.1.2 Thallium-201
8.1.1.3 Gallium-67
8.1.1.4 Iodine-123
8.1.1.5 Other SPECT Isotopes
8.1.2 PET Radiopharmaceuticals
8.1.2.1 F-18
8.1.2.2 Ru-82
8.1.2.3 Other PET Isotopes
8.2 Therapeutic Nuclear Medicine
8.2.1 Alpha Emitters
8.2.1.1 Ra-223
8.2.2 Beta Emitters
8.2.2.1 Iodine-131
8.2.2.2 Yttrium-90
8.2.2.3 Samarium-153
8.2.2.4 Lutetium-177
8.2.2.5 Rhenium-186
8.2.2.6 Other Beta Emitters
8.3 Brachytherapy Isotopes
8.3.1 Iodine-125
8.3.2 Palladium-103
8.3.3 Cesium-131
8.3.4 Iridium-192
8.3.5 Other Brachytherapy Isotopes
Chapter 9 Global Nuclear Medicine/Radiopharmaceuticals Market by Application Estimation and Forecast, 2019 - 2025 (USD Billion)
9.1 Diagnostic Applications
9.1.1 SPECT Applications
9.1.1.1 Cardiology
9.1.1.2 Bone Scans
9.1.1.3 Thyroid Applications
9.1.1.4 Pulmonary Scans
9.1.1.5 Other SPECT Applications
9.1.2 PET Applications
9.1.2.1 Oncology
9.1.2.2 Cardiology
9.1.2.3 Neurology
9.1.2.4 Other PET Applications
9.1.3 Therapeutic Applications
9.1.3.1 Thyroid Indications
9.1.3.2 Bone Metastasis
9.1.3.3 Lymphoma
9.1.3.4 Endocrine Tumors
9.1.3.5 Other Indications
Chapter 10 Global Nuclear Medicine/Radiopharmaceuticals Market by Procedural Volume Assessment Estimation and Forecast, 2019 - 2025 (USD Billion)
10.1 Diagnostic Procedures
10.1.1 SPECT Procedures
10.1.2 PET Procedures
10.2 Therapeutic Procedures
10.2.1 Beta Emitter Procedures
10.2.2 Alpha Emitter Procedures
10.2.3 Brachytherapy Procedures
Chapter 11 Appendix
11.1 Data Sources
11.2 Abbreviations
11.3 About US
11.4 Disclaimer
11.5 Key Notes
Table 1 Global Nuclear Medicine/Radiopharmaceuticals Market, by Region, 2019 - 2025 (USD Billion)
Table2 Global Nuclear Medicine/Radiopharmaceuticals Market, by Type, 2019 - 2025 (USD Billion)
Table3 Global Nuclear Medicine/Radiopharmaceuticals Market, by Application, 2019 - 2025 (USD Billion)
Table4 Global Nuclear Medicine/Radiopharmaceuticals Market, by Procedural Volume Assessment, 2019 - 2025 (USD Billion)
Table5North America Nuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table6North America Nuclear Medicine/Radiopharmaceuticals Market by Type 2019 - 2025 (USD Billion)
Table7North America Nuclear Medicine/Radiopharmaceuticals Market by Application 2019 - 2025 (USD Billion)
Table8North America Nuclear Medicine/Radiopharmaceuticals Market by Procedural Volume Assessment 2019 - 2025 (USD Billion)
Table9US Nuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table10Canada Nuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table11Europe Nuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table12Europe Nuclear Medicine/Radiopharmaceuticals Market by Type 2019 - 2025 (USD Billion)
Table13Europe Nuclear Medicine/Radiopharmaceuticals Market by Application 2019 - 2025 (USD Billion)
Table14Europe Nuclear Medicine/Radiopharmaceuticals Market by Procedural Volume Assessment 2019 - 2025 (USD Billion)
Table15 UK Nuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table16GermanyNuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table17France Nuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table18Spain Nuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table19ItalyNuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table20Russia& CIS Nuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table21Rest of Europe Nuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table22Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table23Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market by Type 2019 - 2025 (USD Billion)
Table24Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market by Application 2019 - 2025 (USD Billion)
Table25Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market by Procedural Volume Assessment 2019 - 2025 (USD Billion)
Table26ChinaNuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table27Japan Nuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table28IndiaNuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table29South Korea Nuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table30ASEAN Nuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table31Rest of Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table32Latin America Nuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table33Latin America Nuclear Medicine/Radiopharmaceuticals Market by Type 2019 - 2025 (USD Billion)
Table34Latin America Nuclear Medicine/Radiopharmaceuticals Market by Application 2019 - 2025 (USD Billion)
Table35Latin America Nuclear Medicine/Radiopharmaceuticals Market by Procedural Volume Assessment 2019 - 2025 (USD Billion)
Table36 Brazil Nuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table37 Argentina Nuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table38 Rest of Latin America Nuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table39Middle East Nuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table40 Middle East Nuclear Medicine/Radiopharmaceuticals Market by Type 2019 - 2025 (USD Billion)
Table41Middle East Nuclear Medicine/Radiopharmaceuticals Market by Application 2019 - 2025 (USD Billion)
Table42Middle East Nuclear Medicine/Radiopharmaceuticals Market by Procedural Volume Assessment 2019 - 2025 (USD Billion)
Table43Africa Nuclear Medicine/Radiopharmaceuticals Market2019 - 2025 (USD Billion)
Table44 Africa Nuclear Medicine/Radiopharmaceuticals Market by Type 2019 - 2025 (USD Billion)
Table45Africa Nuclear Medicine/Radiopharmaceuticals Market by Application 2019 - 2025 (USD Billion)
Table46Africa Nuclear Medicine/Radiopharmaceuticals Market by Procedural Volume Assessment 2019 - 2025 (USD Billion)
Fig. 1 Primary Research Method
Fig. 2 Secondary Research Method
Fig. 3 Value chain analysis
Fig. 4 PESTEL Analysis
Fig. 5 SWOT Analysis
Fig. 6 Porters Five forces analysis
Fig. 7 Nuclear Medicine/Radiopharmaceuticals Market: Penetration & growth prospect mapping
Fig. 8 Nuclear Medicine/Radiopharmaceuticals Market: Competitive snapshot
Fig. 9 Nuclear Medicine/Radiopharmaceuticals Market: Segmental snapshot
Fig. 10 Market Overview
Fig. 11 Nuclear Medicine/Radiopharmaceuticals Market: Product Analysis, 2019 - 2025
Fig. 12 Nuclear Medicine/Radiopharmaceuticals Market: Regional Analysis, 2019 - 2025
Fig. 13 Nuclear Medicine/Radiopharmaceuticals Market: Competitive Matrix
Fig. 14 Nuclear Medicine/Radiopharmaceuticals Market: Revenue Mix